Archives of Pediatric Infectious Diseases

Published by: Kowsar

Treatment Outcomes of Adolescents With Drug-Resistant Tuberculosis in Resource-Constrained Settings

Vicente Ausina 1 , 2 , 3 , * and Carlos Rodrigo 4 , 5
Authors Information
1 Service of Microbiology, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
2 Department of Genetic and Microbiology, Universitat Autonoma of Barcelona, School of Medicine, Barcelona, Spain
3 CIBERES, Instituto de Salud Carlos III, Madrid, Spain
4 Department of Pediatrics, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
5 Department of Pediatrics, Universitat Autonoma of Barcelona, School of Medicine, Barcelona, Spain
Article information
  • Archives of Pediatric Infectious Diseases: October 01, 2015, 3 (4); e30512
  • Published Online: September 16, 2015
  • Article Type: Letter
  • Received: June 4, 2015
  • Accepted: June 28, 2015
  • DOI: 10.5812/pedinfect.30512

To Cite: Ausina V, Rodrigo C. Treatment Outcomes of Adolescents With Drug-Resistant Tuberculosis in Resource-Constrained Settings, Arch Pediatr Infect Dis. 2015 ; 3(4):e30512. doi: 10.5812/pedinfect.30512.

Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnote
References
  • 1. Moyo S, Furin JJ, Hughes J, Daniels J, Snyman L, Muller O, et al. Outcomes in Adolescents Undergoing Treatment for Drug-Resistant Tuberculosis in Cape Town, South Africa, 2008-2013. Arch Pediatr Infect Dis. 2015; 3(1TB): 17934
  • 2. Cox H, Hughes J, Daniels J, Azevedo V, McDermid C, Poolman M, et al. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa. Int J Tuberc Lung Dis. 2014; 18(4): 441-8[PubMed]
  • 3. Cox HS, McDermid C, Azevedo V, Muller O, Coetzee D, Simpson J, et al. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One. 2010; 5(11)[PubMed]
  • 4. Frontieres MS. Scaling up diagnosis and treatment of drug-resistant tuberculosis in Khayelitsha,. 2011;
  • 5. Taddeo D, Egedy M, Frappier JY. Adherence to treatment in adolescents. Paediatr Child Health. 2008; 13(1): 19-24[PubMed]
  • 6. Isaakidis P, Paryani R, Khan S, Mansoor H, Manglani M, Valiyakath A, et al. Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India. PLoS One. 2013; 8(7)[PubMed]
  • 7. Global tuberculosis report 2014. 2014;
  • 8. Global Tuberculosis Report 2012. WHO, Geneva, Switzerland. 2012;
  • 9. Tasneen R, Williams K, Amoabeng O, Minkowski A, Mdluli KE, Upton AM, et al. Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis. Antimicrob Agents Chemother. 2015; 59(1): 129-35[PubMed]
  • 10. Dhar N, Dubee V, Ballell L, Cuinet G, Hugonnet JE, Signorino-Gelo F, et al. Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable beta-lactam antibiotic. Antimicrob Agents Chemother. 2015; 59(2): 1308-19[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments